BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3802391)

  • 1. Inhibition by indomethacin and 5,8,11,14-eicosatetraynoic acid of the induction of rat hepatic ornithine decarboxylase by the tumor promoters phenobarbital and 12-O-tetradecanoylphorbol-13-acetate in vivo.
    van Rooijen LA; Uijtewaal B; Bisschop A
    Carcinogenesis; 1987 Jan; 8(1):191-2. PubMed ID: 3802391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of rat hepatic ornithine decarboxylase by the tumor promotors 12-O-tetradecanoylphorbol-13-acetate and phenobarbital in vivo; effect of retinyl-acetate.
    Bisschop A; van Rooijen LA; Derks HJ; van Wijk R
    Carcinogenesis; 1981; 2(12):1283-7. PubMed ID: 7326828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo.
    Uzumaki H; Yamamoto S; Kato R
    Carcinogenesis; 1986 Feb; 7(2):289-94. PubMed ID: 3081271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice.
    Fischer SM; Fürstenberger G; Marks F; Slaga TJ
    Cancer Res; 1987 Jun; 47(12):3174-9. PubMed ID: 3107806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis.
    Jiang H; Yamamoto S; Kato R
    Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
    Hashiba H; Fukushima M; Chida K; Kuroki T
    Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo induction of rat hepatic ornithine decarboxylase and plasminogen activator by 12-O-tetradecanoylphorbol 13-acetate.
    Buckley AR; Putnam CW; Russell DH
    Biochim Biophys Acta; 1985 Jul; 841(1):127-30. PubMed ID: 4040399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose, time and route dependency of the induction of rat hepatic ornithine decarboxylase by 12-tetradecanoylphorbol 13-acetate.
    Mitra A; Richards I; Kulkarni AP
    Drug Chem Toxicol; 1992; 15(1):67-79. PubMed ID: 1555524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostaglandin E1 in ornithine decarboxylase induction by tumor promoters.
    Ordman AB; Simsiman RC; Cleaveland JS; Boutwell RK
    Int J Cancer; 1986 Mar; 37(3):445-9. PubMed ID: 3081453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells is inhibited by lipoxygenase inhibitors but not by cyclooxygenase inhibitors.
    Yamamoto S; Sasakawa N; Kiyoto I; Nakadate T; Kato R
    Eur J Pharmacol; 1987 Nov; 144(1):101-3. PubMed ID: 3125055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate in mouse skin by sphingosine sulfate.
    Enkvetchakul B; Merrill AH; Birt DF
    Carcinogenesis; 1989 Feb; 10(2):379-81. PubMed ID: 2912589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1,8-dihydroxy-9-anthrone (anthralin) on rat hepatic ornithine decarboxylase activity in vivo.
    Bisschop A; Vankan PM; Uijtewaal B; van Wijk R
    Cancer Lett; 1984 Jun; 23(2):151-7. PubMed ID: 6744241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine decarboxylase in rat skin: 2. Differential response to hair plucking and a tumor promoter.
    Lesiewicz J; Morrison DM; Goldsmith LA
    J Invest Dermatol; 1980 Nov; 75(5):411-6. PubMed ID: 7430708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between induction of rat hepatic ornithine decarboxylase activity by tumor promoters 12-O-tetradecanoylphorbol-13-acetate and phenobarbital and levels of the polyamines putrescine, spermidine and spermine, in vivo; differential effects of retinyl-acetate.
    Van Rooijen LA; Derks HJ; Van Wijk R; Bisschop A
    Carcinogenesis; 1984 Feb; 5(2):225-9. PubMed ID: 6697440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of butyric acid on 12-O-tetradecanoylphorbol-13-acetate-(TPA) induced mouse skin ornithine decarboxylase (ODC).
    Gupta KP; Mehrotra NK
    Carcinogenesis; 1987 Nov; 8(11):1667-70. PubMed ID: 3664957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mouse epidermal ornithine decarboxylase activity by the tumour promoter 12-O-tetradecanoylphorbol 13-acetate involves increased amounts of both enzyme protein and messenger RNA.
    Verma AK; Erickson D; Dolnick BJ
    Biochem J; 1986 Jul; 237(1):297-300. PubMed ID: 3099748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
    Takigawa M; Simsiman RC; Boutwell RK
    Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis.
    Aizu E; Yamamoto S; Nakadate T; Kiyoto I; Kato R
    Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.